Assessment of chemotherapy-induced DNA damage in peripheral blood leukocytes of cancer patients using the alkaline comet assay

Teratogenesis Carcinogenesis and Mutagenesis

Volumn 22, Issue 1, 2002, Pages 13-30

  Kopjar, Nevenka ^a   Garaj Vrhovac, Vera ^b   Milas, Ivan ^b  

^a INSTITUTE FOR MEDICAL RESEARCH AND OCCUPATIONAL HEALTH   (Croatia)

^b SESTRE MILOSRDNICE UNIVERSITY HOSPITAL   (Croatia)

Author keywords

Antineoplastic drugs; Biomarker of exposure; Cancer chemotherapy protocols; DNA lesions; Interindividual differences in response; Microgel electrophoresis; Second cancer risks

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN; CYCLOPHOSPHAMIDE; DEXAMETHASONE; DNA; DOXORUBICIN; FLUOROURACIL; FOLINIC ACID; LEUCOVORIN 30; METHOTREXATE; PREDNISONE; VINCRISTINE; VINCRISTINE SULFATE;

ADULT; ALKALINE COMET ASSAY; ANALYTIC METHOD; ARTICLE; BIOLOGICAL MONITORING; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER PATIENT; CANCER RISK; CLINICAL ARTICLE; CLINICAL PROTOCOL; COLON CANCER; CYTOGENETICS; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DNA DAMAGE; DNA DETERMINATION; EARLY DIAGNOSIS; EVALUATION; FEMALE; HUMAN; INDIVIDUALITY; MALE; NONHODGKIN LYMPHOMA; PERIPHERAL LYMPHOCYTE; POLYPHARMACY; PRIORITY JOURNAL; QUANTITATIVE DIAGNOSIS; SECOND CANCER; STOMACH CANCER;

ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; COMET ASSAY; DNA DAMAGE; DNA REPAIR; DNA, NEOPLASM; FEMALE; HUMANS; LYMPHOCYTES; MALE; MIDDLE AGED; NEOPLASMS;

EID: 0036136934     PISSN: 02703211     EISSN: None     Source Type: Journal    
DOI: 10.1002/tcm.1035     Document Type: Article

References (53)

1. Monitoring occupational exposure to cancer chemotherapy drugs
2. Genotoxic effects of radiotherapy and chemotherapy on the circulating lymphocytes of breast cancer patients. II Alteration of DNA repair and chromosome radiosensitivity
3. Chemistry of drug-induced DNA lesions
4. Analysis of chromate-induced DNA-protein crosslinks with the comet assay
5. Induction of apoptosis by bleomycin in resting and cycling human lymphocytes
6. Human effect monitoring in cases of occupational exposure to antineoplastic drugs: A method comparison
7. Microgel electrophoresis assay (comet test) and SGE analysis in human lymphocytes from 100 normal subjects
8. Comet assay in human biomonitoring studies: Reliability, validation, and applications
9. Alkaline single cell gel electrophoresis of DNA fragments in biomonitoring for genotoxicity: An introductory study on healthy human volunteers
10. DNA damage and repair in individual cells: Applications of the comet assay in radiobiology
11. Single cell gel electrophoresis assay: Sensitivity of peripheral white blood cells in human population studies
12. Pesticide-induced primary DNA damage in peripheral blood leukocytes of farm workers evaluated by the computerized 'comet' assay
13. Application of the alkaline comet assay in human biomonitoring for genotoxicity: A study on Croatian medical personnel handling antineoplastic drugs
14. A simple technique for quantitation of low levels of DNA damage in individual cells
15. The concepts of tail moment and tail inertia in the single cell gel electrophoresis assay
16. The comet assay in clinical practice
17. The comet assay: A comprehensive review
18. Comet assay for nuclear DNA damage
19. Single cell gel/comet assay: Guidelines for in vitro and in vivo genetic toxicology testing
20. Consequences of the resistance to drug-induced topoisomerase II-mediated DNA cleavage
21. Evaluation of the porphyrogenic risk of antineoplastics
22. Mutagenesis after cancer therapy
23. Treatment-related leukemia in breast cancer patients treated with fluorouracil-doxorubicin-cyclophosphamide combination adjuvant chemotherapy: The University of Texas M.D. Anderson Cancer Center experience
24. Second malignant neoplasms occurring in survivors of osteosarcoma
25. Risk of secondary myeloid leukemia and myelodysplastic syndrome following standard-dose chemotherapy or high dose chemotherapy with stem cell support in patients with potentially curable malignancies
26. Secondary leukemia or myelodysplastic syndrome after treatment with epipodophyllotoxicns
27. In vivo mutations in human blood cells: Biomarkers for molecular epidemiology
28. Application of biological markers in cancer environmental epidemiology
29. Molecular epidemiology studies on occupational and environmental exposure to mutagens and carcinogens, 1997-1999
30. Considerations for population monitoring using cytogenetic techniques
31. High-dose combination alkylating agents with autologous bonemarrow support in patients with breast cancer: Preliminary assessment of DNA damage in peripheral blood lymphocytes using the single-cell gel electrophoresis assay
32. Alkaline single-cell gel electrophoresis and human biomonitoring for genotoxicity: A pilot study on breast cancer patients undergoing chemotherapy including cyclophosphamide
33. Measurement of DNA cross-linking in patients on ifosfamide therapy using the single cell gel electrophoresis (comet) assay
34. DNA damaging effect of cyclophosphamide on human blood cells in vivo and in vitro studied with the single-cell gel test (comet assay)
35. Bleomycin-induced DNA damage and its removal in lymphocytes of breast cancer patients studied by comet assay
36. Significance of lymphocytic sister chromatid exchange frequencies in ovarian cancer patients
37. Common fragile site expression and genetic predisposition to breast cancer
38. Induced micronucleus frequencies in peripheral lymphocytes as a screening test for carriers of a BRCA 1 mutation in breast cancer families
39. Cytogenetic studies in lymphocytes of patients with rectal cancer
40. Modulation of fluorouracil by N-(Phosphonacetyl)-L-aspartate, a review
41. Synergism and antagonism in cancer chemotherapy
42. Application of cytogenetic endpoints and Comet assay on human lymphocytes treated with vincristine in vitro
43. The origins of DNA strand breaks: A consequence of DNA damage, DNA repair or apoptosis
44. Sisterchromatid exchanges, chromosomal aberrations and cytotoxicity produced by topoisomerase II-targeted drugs in sensitive (A2780) and resistant (A2780-DX3) human ovarian cancer cells: Correlations with the formation of DNA double-strand breaks
45. Cisplatin-DNA damage and repair in peripheral blood leukocytes in vivo and in vitro
46. Analysis of DNA alkylation damage and repair in mammalian cells by the comet assay
47. Sizing highly fragmented DNA in individual apoptotic cells using the comet assay and a DNA crosslinking agent
48. Detection of DNA lesions induced by chemical mutagens by the single cell electrophoresis (comet) assay 1: Relationship between the onset of DNA damage and the characteristics of mutagens
49. Lack of adverse effect of smoking habit on DNA strand breakage and base damage, as revealed by the alkaline comet assay
50. Cyclophosphamide: Review of its mutagenicity for an assessment of potential germ cell risks
51. Melphalan may be a more potent leukemogen than cyclophosphamide
52. Risk of leukaemia in ovarian tumor and breast cancer patients following treatment by cyclophosphamide
53. Chemical degradation of wastes of antineoplastic agents: Cyclophosphamide, ifosfamide and melphalan